Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Hyamedix ApS
APS
Active
Advertising protection
CVR 39177749
Nordre Fasanvej 215, 2000
Frederiksberg
Manufacture of basic pharmaceutical products
·
NACE 2110
Est. 2017 · 8 years old
2 employees
www.hyamedix.com
Monitor
Share
Denmark
/
Companies
/
Manufacture of basic pharmaceutical products
/
Hyamedix ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
4M
2M
-1M
-3M
-5M
2021: -3M
-3M
2021
2022: -2M (+33% vs 2021)
-2M
+33%
2022
2023: 0M (+100% vs 2022)
0M
+100%
2023
2024: 0M
0M
2024
2025: 2M
2M
2025
EBITDA
DKK millions
0M
-2M
-4M
-6M
-7M
2021: -6M
-6M
2021
2022: -5M (+17% vs 2021)
-5M
+17%
2022
2023: -2M (+60% vs 2022)
-2M
+60%
2023
2024: -2M (0% vs 2023)
-2M
0%
2024
2025: 0M (+100% vs 2024)
0M
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
1.843
-36
48
-2.134
-2.705
Staff expenses
-1.678
-1.744
-1.979
-2.753
-2.878
EBITDA
166
-1.780
-1.931
-4.888
-5.582
Depreciation & amort.
-9
-0
-0
-0
-0
EBIT
157
-1.780
-1.931
-4.888
-5.582
Net financials
-993
-694
-521
-319
-243
Profit before tax
-836
-2.474
-2.452
-5.207
-5.825
Tax
50
-1.103
299
-0
149
Net profit
-887
-1.371
-2.751
-5.207
-5.974
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
1.576
2.301
4.484
1.853
3.561
Equity
-10.060
-9.173
-7.803
-5.052
-3.855
Long-term debt
10.083
8.778
8.436
6.417
6.117
Short-term debt
1.553
2.696
3.851
489
1.300
Total debt
11.636
11.474
12.287
6.906
7.417
Financial ratios
5-year trend
EBITDA margin (of gross profit)
9,0 %
This company
2021
2025
Equity ratio
-638,4 %
This company
38,2 %
Market median
This company
Market median
>999% below market
2021
2025
Return on equity
—
This company
18,4 %
Market median
This company
Market median
2021
2025
Net profit margin (of gross profit)
-48,1 %
This company
2021
2025
Asset turnover (of gross profit)
1,17×
This company
2021
2025
Debt / equity
—
This company
0,62×
Market median
This company
Market median
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Hyamedix ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
